Non-invasive Traction Therapy – Project Sale

The company is a technology leader in the field of hypoxia training, specializing in the development, distribution, and servicing of innovative Interval Hypoxia-Hyperoxia Therapy (IHHT) and CO₂ systems. It serves a wide range of sectors, including medicine, therapy, fitness, wellness, and the consumer market, and has established itself as a leader in its field through its customer-focused innovation and technical expertise. With its focus on high-quality product solutions and a comprehensive range of services, the company distinguishes itself through its ability to support both individual clients and institutional customers with customized and effective therapeutic approaches.

Based in North Rhine-Westphalia, the company has made a name for itself over two decades in the trade of specialized medical products. With an established base of existing customers who account for 95% of its revenue, the company demonstrates excellent customer loyalty and stability in the medical device market. Its strength lies in the planning, project management, and sale of these products, with hospitals, medical care centers (MVZ), private practices, and specialty retailers forming the core of its client base. Through its focus on specialized medical needs, the company delivers significant added value and continuously taps into new opportunities in a critical sector.

The company has been an established and profitable player in the consulting sector for the pharmaceutical and healthcare markets for over four decades, distinguished by its tailored software solutions and specialized consulting services. With in-depth industry expertise, a focus on the DACH region, and involvement in global projects, it helps pharmaceutical and medical technology companies optimize their workflows and processes. Thanks to its ability to boost efficiency and productivity through innovative digital solutions, the company enjoys a respected position in a highly competitive environment.

A "ready to scale" wellness technology company specializing in cold and contrast therapy is for sale at a purchase price of 200,000 euros . The company holds an EU patent application for an ice bath that generates real ice directly in the tub and is positioned in the rapidly growing market for modern recovery solutions. The company has already achieved successful market validation and generated approximately 138,000 euros in revenue in 2025 through organic growth alone . In Q1 2026, it has already generated approximately 106,000 euros in revenue . The sales structure includes a fully functional online store, established supply chains, and initial distribution partnerships in the B2B and B2C sectors. A key investment highlight: The purchase price of 200,000 euros includes an extensive inventory with a retail value of approximately 230,000 euros . This inventory can be used immediately to generate revenue without further reinvestment . In addition, the company is eligible for BAFA-INVEST funding (25% grant) for investors. The sale is taking place for health reasons. To ensure the company’s scaling up to market leadership, the current managing director will be available long-term for a transition phase as well as for ongoing strategic consulting .

The company positions itself as a pioneer in the field of functional diagnostics and holistic therapies, complemented by its unique technological expertise in hemoperfusion. Its value proposition is based on an innovative concept that enables diagnosis and the development of treatment plans with minimal time commitment for patients, making it particularly attractive to individuals with chronic or autoimmune diseases, as well as in the field of longevity medicine. Key success factors include its unique medical positioning through specialized diagnostics, the potential for scaling via licensing models, and a strong network of experts and partners.